WallStreetZenWallStreetZen

NASDAQ: CABA
Cabaletta Bio Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

CABA earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$57.5M
Current Profit Margin
0%

CABA Return on Equity

Current Company
-50.4%
Current Industry
1.4%
Current Market
22.1%
CABA's Return on Equity (-50.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CABA announces earnings.

CABA Return on Assets

Current Company
-46.3%
Current Industry
-1.3%
CABA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CABA Return on Capital Employed

Current Company
-32.62%
Current Industry
12.1%
CABA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CABA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CABA$0.00-$52.58M-$57.46MN/AN/A
EXAI$28.41M-$214.57M-$192.43M+38.32%N/A
EDIT$19.32M-$210.06M-$205.79M-1.89%N/A
VERA$0.00-$104.74M-$107.35MN/AN/A
TYRA$0.00-$50.22M-$50.56MN/AN/A
View Top Biotech Stocks

CABA earnings dates

Next earnings date
Nov 8, 2023

Cabaletta Bio Earnings & Revenue FAQ

What were CABA's earnings last quarter?

On Invalid Date, Cabaletta Bio (NASDAQ: CABA) reported Q2 2023 earnings per share (EPS) of -$0.37, up 17.78% year over year. Total Cabaletta Bio earnings for the quarter were -$14.49 million. In the same quarter last year, Cabaletta Bio's earnings per share (EPS) was -$0.45.

If you're new to stock investing, here's how to buy Cabaletta Bio stock.

What was CABA's earnings growth in the past year?

As of Q3 2023, Cabaletta Bio's earnings has grown year over year. Cabaletta Bio's earnings in the past year totalled -$57.46 million.

What is CABA's earnings date?

Cabaletta Bio's earnings date is Invalid Date. Add CABA to your watchlist to be reminded of CABA's next earnings announcement.

What was CABA's revenue last quarter?

On Invalid Date, Cabaletta Bio (NASDAQ: CABA) reported Q2 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Cabaletta Bio's revenue was $0.00.

What was CABA's revenue growth in the past year?

As of Q3 2023, Cabaletta Bio's revenue has grown null year over year. Cabaletta Bio's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.